医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
9期
147-148
,共2页
血小板输注无效%阈值%血小板校正增加值(CCI)%血小板回收率(RPR)
血小闆輸註無效%閾值%血小闆校正增加值(CCI)%血小闆迴收率(RPR)
혈소판수주무효%역치%혈소판교정증가치(CCI)%혈소판회수솔(RPR)
Platelets transfusion is invalid%The added value of threshold%Platelet correction (CCI)%Platelet recovery (RPR)
目的：了解血小板输注临床指征，分析血小板输注后效果，为临床治疗出血性疾病提供依据。方法对2010年1月~2013年6月在医院住院期间，输注血小板的患者，根据患者的临床表现及血小板计数数值，将血小板输注分为治疗性输注和预防性；在输注前后各1 h、输注后24 h分别采集血常规计数血小板，监测血小板输注阈值及输注疗效。结果预防性输注血小板比例占29.32%，输注阈值<10×109/L有39.73%、阈值10～20×109/L有27.40%、阈值20～50×109/L有32.88%，预防性输注后血小板平均升高12.05×109/L；治疗性输注血小板输比例占70.68%，输注阈值<10×109/L有51.99%、阈值<10～20×109/L有33.52%、阈值20～50×109/L有50.80%，治疗性输注血小板平均升高7.1×109/L。结论临床使用血小板目的大多为治疗性输注（70.68%）；血小板计数越低输注有效率越高；治疗性输注与预防性输注在输注前血小板计数值范围相同的情况下，二者血小板增高值无显著性差异；血小板输注阈值应严格结合患者临床症状，预防性输注不可滥用。
目的：瞭解血小闆輸註臨床指徵，分析血小闆輸註後效果，為臨床治療齣血性疾病提供依據。方法對2010年1月~2013年6月在醫院住院期間，輸註血小闆的患者，根據患者的臨床錶現及血小闆計數數值，將血小闆輸註分為治療性輸註和預防性；在輸註前後各1 h、輸註後24 h分彆採集血常規計數血小闆，鑑測血小闆輸註閾值及輸註療效。結果預防性輸註血小闆比例佔29.32%，輸註閾值<10×109/L有39.73%、閾值10～20×109/L有27.40%、閾值20～50×109/L有32.88%，預防性輸註後血小闆平均升高12.05×109/L；治療性輸註血小闆輸比例佔70.68%，輸註閾值<10×109/L有51.99%、閾值<10～20×109/L有33.52%、閾值20～50×109/L有50.80%，治療性輸註血小闆平均升高7.1×109/L。結論臨床使用血小闆目的大多為治療性輸註（70.68%）；血小闆計數越低輸註有效率越高；治療性輸註與預防性輸註在輸註前血小闆計數值範圍相同的情況下，二者血小闆增高值無顯著性差異；血小闆輸註閾值應嚴格結閤患者臨床癥狀，預防性輸註不可濫用。
목적：료해혈소판수주림상지정，분석혈소판수주후효과，위림상치료출혈성질병제공의거。방법대2010년1월~2013년6월재의원주원기간，수주혈소판적환자，근거환자적림상표현급혈소판계수수치，장혈소판수주분위치료성수주화예방성；재수주전후각1 h、수주후24 h분별채집혈상규계수혈소판，감측혈소판수주역치급수주료효。결과예방성수주혈소판비례점29.32%，수주역치<10×109/L유39.73%、역치10～20×109/L유27.40%、역치20～50×109/L유32.88%，예방성수주후혈소판평균승고12.05×109/L；치료성수주혈소판수비례점70.68%，수주역치<10×109/L유51.99%、역치<10～20×109/L유33.52%、역치20～50×109/L유50.80%，치료성수주혈소판평균승고7.1×109/L。결론림상사용혈소판목적대다위치료성수주（70.68%）；혈소판계수월저수주유효솔월고；치료성수주여예방성수주재수주전혈소판계수치범위상동적정황하，이자혈소판증고치무현저성차이；혈소판수주역치응엄격결합환자림상증상，예방성수주불가람용。
Objective to understand the clinical indications, platelet transfusion after analysis of platelet infusion ef ect, provide the basis for clinical treatment of hemorrhagic disease. Methods: In January 2010 to June 2013 in the hospital, platelet transfusion patients, according to the clinical manifestations and the platelet count in patients with numerical, infusion of platelet infusion can be divided into therapeutic and preventive. In the 1 hour before and after the infusion, 24 hours after infusion were gathering routine blood count, platelet infusion of monitoring platelet transfusion threshold value and curative ef ect. Results: prophylactic platelet transfusion rate was 29.32%, the infusion threshold is 39.73% less than 10 x 109 / L, the threshold between 10 to 20 x 109 / L 27.40%, threshold between 20 ~ 50 * 109 / L 32.88%, prophylactic platelet after infusion by an average of 12.05 x 109 /L; Therapeutic platelet lose proportion (70.68%), infusion 51.99%threshold value is less than 10 x 109/L, the threshold value is less than 10~20 x 109/L 33.52%, threshold between 20~50*109/L 50.80%, therapeutic platelet transfusion by an average 7.1 x 109 /L;Conclusion: the clinical use of platelet purpose mostly therapeutic infusion (70.68%); The lower platelet count infusion ef iciency is higher; Infusion of therapeutic and preventive infusion before infusion platelet count value range of the same cases, there was no significant dif erence between both increased platelet values; Platelets transfusion threshold should be strict in combination with clinical symptoms, preventive infusion is not abused.
